Please login to the form below

Not currently logged in

stem cells

This page shows the latest stem cells news and features for those working in and with pharma, biotech and healthcare.

Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy

Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy

Dr Asit Parikh, head of gastroenterology therapeutic area unit at Takeda, said: “Today’s marketing authorisation, the first for an allogeneic stem cell therapy, represents a positive advancement in the treatment ... Alofisel, which works by a local

Latest news

More from news
Approximately 6 fully matching, plus 88 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2018

    Takeda moves in neurodegenerative diseases and stem cell therapy. Meanwhile Takeda, ranked 4. ... Option exercise (2 options). 640. TiGenix/Takeda. Cx601, lead asset, allogeneic expanded adipose-derived stem cells (eASC) locally administered for

  • Deal Watch December 2016 Deal Watch December 2016

    320. Evotec (Germany). Celgene (US). Discovery collaboration. Induced pluripotent stem cells for neurodegenerative diseases. ... the affinity and selectivity of antibodies with the properties of small molecules, Evotec's induced pluripotent stem cells

  • Deal Watch July 2016 Deal Watch July 2016

    It is a humanised inducible co-stimulator (ICOS) agonist antibody, designed to both stimulate T effector cells and selectively reduce intra-tumoural T regulatory cells. ... Acquisition. 416. TiGenix/ Takeda. Cx601 - Stem cell treatment for perianal

  • Deal Watch June 2016 Deal Watch June 2016

    domain. For XmAb14045 the tumour antigen binding domain is CD123 (highly expressed on AML cells and leukaemic stem cells) and for XmAb13676 the tumour antigen binding domain is CD20 (highly expressed ... on B-cell tumor cells, including chronic

  • Stronger together Stronger together

    As new medical technologies like stem cells and personalised medicines continue to mature, “ we are at the state when we need to really make sure that the patients are more included

More from intelligence
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....